Related Experiment Video
Updated: Jun 6, 2025

Bioluminescent Bacterial Imaging In Vivo
Published on: November 4, 2012
Living Engineered Bacterial Therapeutics: Emerging Affordable Precision Interventions
Rajkamal Srivastava1,2, Cammie F Lesser1,2,3,4
1Center for Bacterial Pathogenesis, Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.
Abstract:
Live biotherapeutic products (LBPs), including engineered bacteria, are rapidly emerging as potential therapeutic interventions. These innovative therapies can serve as live in situ drug delivery platforms for the direct deposition of therapeutic payloads, including complex biologics, at sites of disease. This approach offers a platform likely to enhance therapeutic efficacy and decrease off-target side effects. LBPs also can likely be distributed at a relatively low price point, as their production can be economically scaled up. LBPs represent an exciting new means for ensuring healthy lives and promoting well-being for all ages, aligning with the World Health Organization's sustainable development goal 3.
More Related Videos
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Biological Methods for Microbial Control
Antibiotic Selection
Bacterial Signaling
Gene Regulation in Microbial Communities: Quorum Sensing
Lytic Cycle of Bacteriophages

